- ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2025-01-01
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2025-03-27
Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 273
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273_a&doctype=Standard
-URIDate 2025-03-27
Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 273
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273_a&doctype=Standard
-URIDate 2025-03-27
| Name: |
ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets |
| Namespace Prefix: |
ifrs-full_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
na |
| Period Type: |
duration |